Company Information for ISOGENICA LIMITED
The Mansion Chesterford Research Park, Little Chesterford, Saffron Walden, ESSEX, CB10 1XL,
|
Company Registration Number
03571781
Private Limited Company
Active |
Company Name | |
---|---|
ISOGENICA LIMITED | |
Legal Registered Office | |
The Mansion Chesterford Research Park Little Chesterford Saffron Walden ESSEX CB10 1XL Other companies in CB10 | |
Company Number | 03571781 | |
---|---|---|
Company ID Number | 03571781 | |
Date formed | 1998-05-28 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 2022-12-31 | |
Account next due | 2024-09-30 | |
Latest return | 2024-05-17 | |
Return next due | 2025-05-31 | |
Type of accounts | SMALL |
Last Datalog update: | 2024-05-24 21:52:02 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
ISOGENICA CGL LIMITED | THE MANSION CHESTERFORD RESEARCH PARK LITTLE CHESTERFORD SAFFRON WALDEN ESSEX CB10 1XL | Dissolved | Company formed on the 2011-12-09 | |
ISOGENICA IMG LIMITED | THE MANSION CHESTERFORD RESEARCH PARK LITTLE CHESTERFORD SAFFRON WALDEN ESSEX CB10 1XL | Dissolved | Company formed on the 2012-04-04 |
Officer | Role | Date Appointed |
---|---|---|
BENGT NICLAS ERIKSSON |
||
GORAN OLOF LORENTZ FORSBERG |
||
RENNY PHILIP LEACH |
||
JAN OLOF ERLING LUNDIN |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
ANNA-LOUISE EDWARDS |
Company Secretary | ||
DAVID ALEXANDER BURNS |
Director | ||
CAROLYN ANN RAND |
Company Secretary | ||
CAROLYN ANN RAND |
Director | ||
CHRISTOPHER GRAEME ULLMAN |
Director | ||
KEVIN ROGER KENNETH MATTHEWS |
Director | ||
ANTHONY MICHAEL NIXON |
Company Secretary | ||
PER NORFELDT |
Director | ||
KEVIN JOHN FITZGERALD |
Director | ||
TOMAS LEANDERSON |
Director | ||
DAVID MCGIBNEY |
Director | ||
ULF HILLERBRAND |
Director | ||
SIMON KERRY |
Director | ||
ANTHONY MICHAEL NIXON |
Director | ||
IAN PETER RADFORD |
Company Secretary | ||
STEVEN JOHN POWELL |
Director | ||
ASHBURTON REGISTRARS LIMITED |
Nominated Secretary | ||
AR NOMINEES LIMITED |
Nominated Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
ISOGENICA IMG LIMITED | Director | 2016-06-01 | CURRENT | 2012-04-04 | Dissolved 2016-11-22 | |
ISOGENICA CGL LIMITED | Director | 2016-06-01 | CURRENT | 2011-12-09 | Dissolved 2017-03-14 | |
BIOKAPITAL LIMITED | Director | 2004-02-17 | CURRENT | 2004-02-17 | Active - Proposal to Strike off | |
IRESEARCH LTD | Director | 2003-05-27 | CURRENT | 2003-05-27 | Active - Proposal to Strike off | |
MEDICAL RESEARCH CONSULTANCY LIMITED | Director | 1998-08-10 | CURRENT | 1998-08-05 | Active - Proposal to Strike off |
Job Title | Location | Job description | Date posted |
---|---|---|---|
ISO02 - Principal Antibody Discovery and Engineering Scientist/Team Leader | Cambridge | Isogenica is an established biotechnology company located on the outskirts of Cambridge, UK. We specialise in providing protein engineering to pharmaceutical | |
RS032 - Research Scientist, Gene Library Production and Validation | Cambridge | Isogenica seeks an experienced and highly motivated Research Scientist to join the team on a *fixed term one year maternity cover contract.* Responsibilities | |
RS033 - Research Assistant/Senior Research Assistant | Cambridge | Isogenica seeks an experienced and highly motivated Research Assistant to join the team on a *fixed term 12 month contract* to join the team. Responsibilities |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 17/05/24, WITH UPDATES | ||
DIRECTOR APPOINTED MR TREVOR MICHAEL PHILIPS | ||
DIRECTOR APPOINTED DR PAUL JONATHAN CLEWLOW | ||
APPOINTMENT TERMINATED, DIRECTOR BENGT NICLAS ERIKSSON | ||
SMALL COMPANY ACCOUNTS MADE UP TO 31/12/22 | ||
CONFIRMATION STATEMENT MADE ON 17/05/23, WITH NO UPDATES | ||
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/21 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/22, WITH UPDATES | |
Memorandum articles filed | ||
MEM/ARTS | ARTICLES OF ASSOCIATION | |
Resolutions passed:<ul><li>Resolution passed adopt articles</ul> | ||
RES01 | ADOPT ARTICLES 27/04/22 | |
SH01 | 03/12/21 STATEMENT OF CAPITAL GBP 9066966.6 | |
AP01 | DIRECTOR APPOINTED DR WILLIAM ELDRIDGE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR EMMA LOUISE SCEATS | |
PSC07 | CESSATION OF JAN-OLOF ERLING LUNDIN AS A PERSON OF SIGNIFICANT CONTROL | |
SH01 | 07/07/21 STATEMENT OF CAPITAL GBP 8566966.6 | |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL PER FREDERIK ALEXANDER KAMMERER | |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL BENGT NICLAS ERIKSSON | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/21, WITH UPDATES | |
SH01 | 27/05/21 STATEMENT OF CAPITAL GBP 8566441.6 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BJOERN COCHLOVIUS | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/20 | |
SH01 | 17/09/20 STATEMENT OF CAPITAL GBP 8561456.7 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/20, WITH UPDATES | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/19 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JAN OLOF ERLING LUNDIN | |
AP01 | DIRECTOR APPOINTED DR BJOERN COCHLOVIUS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GORAN OLOF LORENTZ FORSBERG | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/19, WITH UPDATES | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/18 | |
SH01 | 14/02/19 STATEMENT OF CAPITAL GBP 8559016.5 | |
AP01 | DIRECTOR APPOINTED DR EMMA LOUISE SCEATS | |
LATEST SOC | 19/06/18 STATEMENT OF CAPITAL;GBP 8059016.6 | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/05/18, WITH UPDATES | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/17 | |
TM02 | Termination of appointment of Anna-Louise Edwards on 2018-03-08 | |
LATEST SOC | 29/11/17 STATEMENT OF CAPITAL;GBP 8059016.55 | |
SH01 | 29/11/17 STATEMENT OF CAPITAL GBP 8059016.55 | |
LATEST SOC | 11/08/17 STATEMENT OF CAPITAL;GBP 8057981.6 | |
SH01 | 24/07/17 STATEMENT OF CAPITAL GBP 8057981.6 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAVID ALEXANDER BURNS | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/16 | |
LATEST SOC | 20/07/17 STATEMENT OF CAPITAL;GBP 8056981.6 | |
SH01 | 04/07/17 STATEMENT OF CAPITAL GBP 8056981.6 | |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL JAN-OLOF ERLING LUNDIN | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/05/17, WITH UPDATES | |
SH01 | 11/04/17 STATEMENT OF CAPITAL GBP 8056256.6 | |
SH01 | 31/01/17 STATEMENT OF CAPITAL GBP 8046256.60 | |
RES10 | Resolutions passed:
| |
LATEST SOC | 18/11/16 STATEMENT OF CAPITAL;GBP 10773879.83 | |
SH01 | 01/08/16 STATEMENT OF CAPITAL GBP 10773879.83 | |
LATEST SOC | 23/06/16 STATEMENT OF CAPITAL;GBP 10273879.93 | |
AR01 | 28/05/16 ANNUAL RETURN FULL LIST | |
AP03 | Appointment of Ms Anna-Louise Edwards as company secretary on 2016-06-02 | |
TM02 | Termination of appointment of Carolyn Ann Rand on 2016-06-01 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CAROLYN ANN RAND | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
LATEST SOC | 12/08/15 STATEMENT OF CAPITAL;GBP 10273879.83 | |
SH01 | 15/07/15 STATEMENT OF CAPITAL GBP 10273879.83 | |
SH01 | 24/11/14 STATEMENT OF CAPITAL GBP 9773865.568959 | |
AR01 | 28/05/15 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/14 | |
SH01 | 20/02/14 STATEMENT OF CAPITAL GBP 7045956.6 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER ULLMAN | |
AP01 | DIRECTOR APPOINTED MRS CAROLYN ANN RAND | |
RES13 | SHARE OPTIONS 30/06/2014 | |
RES01 | ADOPT ARTICLES 30/06/2014 | |
AP03 | SECRETARY APPOINTED MRS CAROLYN ANN RAND | |
SH01 | 15/10/14 STATEMENT OF CAPITAL GBP 5671173 | |
SH01 | 30/06/14 STATEMENT OF CAPITAL GBP 5671173 | |
AP01 | DIRECTOR APPOINTED DR CHRISTOPHER GRAEME ULLMAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEVIN MATTHEWS | |
LATEST SOC | 17/09/14 STATEMENT OF CAPITAL;GBP 5671173 | |
SH02 | SUB-DIVISION 30/06/14 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/13 | |
AR01 | 28/05/14 FULL LIST | |
AP01 | DIRECTOR APPOINTED MR DAVID ALEXANDER BURNS | |
RES13 | INCREASE IN SHARE CAP 31/03/2014 | |
AUD | AUDITOR'S RESIGNATION | |
AR01 | 28/05/13 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / BENGT NICLAS ERIKSSON / 01/01/2013 | |
SH01 | 20/05/13 STATEMENT OF CAPITAL GBP 5671173 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/12 | |
TM02 | APPOINTMENT TERMINATED, SECRETARY ANTHONY NIXON | |
SH01 | 24/01/13 STATEMENT OF CAPITAL GBP 5657977.75 | |
SH01 | 28/11/12 STATEMENT OF CAPITAL GBP 5657977.75 | |
MG01 | PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 2 | |
AR01 | 28/05/12 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/11 | |
AD01 | REGISTERED OFFICE CHANGED ON 23/04/2012 FROM C/O C/O SAFFERY CHAMPNESS UNEX HOUSE BOURGES BOULEVARD PETERBOROUGH PE1 1NG UNITED KINGDOM | |
AP01 | DIRECTOR APPOINTED GORAN OLOF LORENTZ FORSBERG | |
AD01 | REGISTERED OFFICE CHANGED ON 09/11/2011 FROM STUART HOUSE CITY ROAD PETERBOROUGH PE1 1QF | |
SH01 | 26/09/11 STATEMENT OF CAPITAL GBP 5023977.75 | |
AR01 | 28/05/11 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / JAN OLOF ERLING LUNDIN / 10/06/2011 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / BENGT NICLAS ERIKSSON / 10/06/2011 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/10 | |
SH01 | 30/03/11 STATEMENT OF CAPITAL GBP 5014811.00 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PER NORFELDT | |
AR01 | 28/05/10 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/09 | |
RES01 | ADOPT ARTICLES 25/05/2010 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEVIN FITZGERALD | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR TOMAS LEANDERSON | |
288a | DIRECTOR APPOINTED DR KEVIN ROGER KENNETH MATTHEWS | |
363a | RETURN MADE UP TO 28/05/09; CHANGE OF MEMBERS | |
AA | FULL ACCOUNTS MADE UP TO 31/12/08 | |
363s | RETURN MADE UP TO 28/05/08; CHANGE OF MEMBERS | |
AA | FULL ACCOUNTS MADE UP TO 31/12/07 | |
288b | APPOINTMENT TERMINATED DIRECTOR DAVID MCGIBNEY | |
88(2)R | AD 29/01/08--------- £ SI 2677529@.25=669382 £ IC 4343428/5012810 | |
123 | NC INC ALREADY ADJUSTED 24/01/06 | |
RES04 | £ NC 5000000/5400000 24/0 | |
288a | NEW DIRECTOR APPOINTED | |
AA | FULL ACCOUNTS MADE UP TO 31/12/06 | |
363s | RETURN MADE UP TO 28/05/07; FULL LIST OF MEMBERS | |
403a | DECLARATION OF SATISFACTION OF MORTGAGE/CHARGE | |
88(2)R | AD 12/04/07--------- £ SI 600000@.25=150000 £ IC 2994889/3144889 | |
225 | ACC. REF. DATE SHORTENED FROM 31/05/07 TO 31/12/06 | |
AA | FULL ACCOUNTS MADE UP TO 31/05/06 | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW DIRECTOR APPOINTED | |
363s | RETURN MADE UP TO 28/05/06; CHANGE OF MEMBERS | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AA | FULL ACCOUNTS MADE UP TO 31/05/05 | |
363s | RETURN MADE UP TO 28/05/05; CHANGE OF MEMBERS | |
395 | PARTICULARS OF MORTGAGE/CHARGE | |
AA | FULL ACCOUNTS MADE UP TO 31/05/04 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
363(288) | DIRECTOR'S PARTICULARS CHANGED | |
363s | RETURN MADE UP TO 28/05/04; FULL LIST OF MEMBERS | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
288b | DIRECTOR RESIGNED | |
288a | NEW DIRECTOR APPOINTED | |
AA | FULL ACCOUNTS MADE UP TO 31/05/03 | |
RES13 | SUB DIVIDED 01/08/03 | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
363(288) | DIRECTOR'S PARTICULARS CHANGED | |
363s | RETURN MADE UP TO 28/05/03; CHANGE OF MEMBERS | |
288b | DIRECTOR RESIGNED | |
288b | DIRECTOR RESIGNED |
Total # Mortgages/Charges | 2 |
---|---|
Mortgages/Charges outstanding | 1 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 1 |
Charge Type | Date of Charge | Charge Status | Mortgagee |
---|---|---|---|
DEBENTURE | Outstanding | BARCLAYS BANK PLC | |
LOAN AGREEMENT | Satisfied | ACTIVE BIOTECH AB,DUNROSS & CO AB AND FINTERBANK & TRUST(BAHAMAS)LIMITED |
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on ISOGENICA LIMITED
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as ISOGENICA LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
90262020 | Electronic instruments and apparatus for measuring or checking pressure of liquids or gases (excl. regulators) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29349990 | Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
85234951 | Digital versatile discs "DVD", recorded, for reproducing sound and image or image only (excl. for reproducing representations of instructions, data, sound, and image recorded in a machine-readable binary form, and capable of being manipulated or providing interactivity to a user, by means of an automatic data-processing machine) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
35040090 | Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
84135080 | Reciprocating positive displacement pumps, power-driven (excl. pumps of subheading 8413.11 and 8413.19, fuel, lubricating or cooling medium pumps for internal combustion piston engine, concrete pumps, hydraulic units, dosing pumps and general piston pumps) | |||
70179000 | Laboratory, hygienic or pharmaceutical glassware, whether or not graduated or calibrated (excl. glass having a linear coefficient of expansion <= 5 x 10 -6 per kelvin within a temperature range of 0°C to 300°C or of fused quartz or other fused silica, containers for the conveyance or packing of goods, measuring, checking or medical instruments and apparatus of chapter 90) | |||
90279050 | Parts and accessories of instruments and apparatus for physical or chemical analysis, e.g. polarimeters, refractometers, spectrometers, of instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like and of instruments and apparatus for measuring or checking quantities of heat, sound or light, incl. exposure meters, n.e.s. (excl. of gas or smoke analysis apparatus) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
90279050 | Parts and accessories of instruments and apparatus for physical or chemical analysis, e.g. polarimeters, refractometers, spectrometers, of instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like and of instruments and apparatus for measuring or checking quantities of heat, sound or light, incl. exposure meters, n.e.s. (excl. of gas or smoke analysis apparatus) | |||
90279050 | Parts and accessories of instruments and apparatus for physical or chemical analysis, e.g. polarimeters, refractometers, spectrometers, of instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like and of instruments and apparatus for measuring or checking quantities of heat, sound or light, incl. exposure meters, n.e.s. (excl. of gas or smoke analysis apparatus) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Demonstrating an innovative End-to-End Drug Discovery (E2D2) platform : Collaborative Research and Development | 2012-08-01 | £ 246,990 |
Next Antibody Library Construction for Therapeutics : Smart - Development of Prototype | 2011-10-01 | £ 248,700 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |